Literature DB >> 20479210

Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1.

Jason M Pogue, Brian A Potoski, Keith S Kaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20479210      PMCID： PMC2876408          DOI： 10.1128/AAC.00892-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey.

Authors:  A Erbay; H Bodur; E Akinci; A Colpan
Journal:  J Hosp Infect       Date:  2005-01       Impact factor: 3.926

2.  Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia.

Authors:  James R Beardsley; John C Williamson; James W Johnson; Christopher A Ohl; Tobi B Karchmer; David L Bowton
Journal:  Chest       Date:  2006-09       Impact factor: 9.410

Review 3.  Back to the future: using aminoglycosides again and how to dose them optimally.

Authors:  George L Drusano; Paul G Ambrose; Sujata M Bhavnani; Joseph S Bertino; Ann N Nafziger; Arnold Louie
Journal:  Clin Infect Dis       Date:  2007-08-08       Impact factor: 9.079

4.  Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?

Authors:  Sunil Bhat; Shigeki Fujitani; Brian A Potoski; Blair Capitano; Peter K Linden; Kathleen Shutt; David L Paterson
Journal:  Int J Antimicrob Agents       Date:  2007-08-20       Impact factor: 5.283

5.  Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units.

Authors:  João F P Oliveira; Carolina A Silva; Camila D Barbieri; Giselle M Oliveira; Dirce M T Zanetta; Emmanuel A Burdmann
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

6.  Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.

Authors:  D P Nicolau; C D Freeman; P P Belliveau; C H Nightingale; J W Ross; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

7.  Reference group choice and antibiotic resistance outcomes.

Authors:  Keith S Kaye; John J Engemann; Essy Mozaffari; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883
  7 in total
  2 in total

1.  Risk factors for aminoglycoside-associated nephrotoxicity in surgical intensive care unit patients.

Authors:  Anthony T Gerlach; Stanislaw P Stawicki; Charles H Cook; Claire Murphy
Journal:  Int J Crit Illn Inj Sci       Date:  2011-01

Review 2.  Efficacy and Safety of Plazomicin in the Treatment of Enterobacterales Infections: A Meta-analysis of Randomized Controlled Trials.

Authors:  Kaicheng Yan; Beibei Liang; Guanxuanzi Zhang; Jin Wang; Man Zhu; Yun Cai
Journal:  Open Forum Infect Dis       Date:  2022-08-29       Impact factor: 4.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.